Latest posts from Pharma Blogs


WSJ.com: Health Blog » Insurance Ping Pong Can Aggravate TMJ Pain

Posted 44 minutes ago

If you’re clenching and grinding your teeth more as the stock market tumbles, your angst may get worse when you try to file an insurance claim.

iStockphoto

Disorders of the TMJ ...

[Link]



WSJ.com: Health Blog » Doctors More Likely to Tell Patients About Obvious Errors

Posted 3 hours ago

Consider two medical scenarios.

In one, a child receives an overdose of insulin and is admitted to the intensive care unit. In the other, a doctor overlooks a lab test, which ...

[Link]



Pharmalot » Your Speaker This Evening, Dr. Charles Nemeroff

Posted 3 hours ago

Ever play ‘Whack-A-Mole?’ You know, you smack the little creature on the head whenever it pops up, although it keeps reappearing elsewhere? Well, Emory University’s Charles Nemeroff, who is the latest ...

[Link]



Pharmalot » Your Speaker This Evening, Dr. Charles Nemeroff

Posted 4 hours ago

Ever play ‘Whack-A-Mole?’ You know, you smack the little creature on the head whenever it pops up, although it keeps reappearing elsewhere? Well, Emory University’s Charles Nemeroff, who is the latest ...

[Link]



THE PETER ROST BLOG » The reason the market is crashing.

Posted 6 hours ago

By accessing this site, you are agreeing to comply with and be bound by the terms of use agreement and privacy policy. [Link]



WSJ.com: Health Blog » Dendreon Shares Climb on Promising Prostate Cancer Data

Posted 6 hours ago

Dendreon is back. The beleaguered biotech reported that its prostate cancer vaccine Provenge cut the risk of death by 20% compared with a placebo in a clinical test.

As nearly every ...

[Link]



Pharma Marketing Blog » As I Predicted, Drug Samples Under Attack!

Posted 6 hours ago

First it was direct-to-consumer (DTC) advertising, then free gifts to physicians, followed by pharma-funded continuing medical education (CME). Now the distribution of free Rx drug samples to physicians by pharmaceutical ... [Link]



THE PETER ROST BLOG » Why the bailout isn't working and stock markets tumbling.

Posted 6 hours ago

By accessing this site, you are agreeing to comply with and be bound by the terms of use agreement and privacy policy. [Link]



Pharmalot » Samples Don’t Reach Poor Kids & Have Safety Risks

Posted 6 hours ago

In an ideal world, free samples would help uninsured patients get a jump on treatment they may not otherwise be able to obtain. But a new study in Pediatrics finds that ...

[Link]



WSJ.com: Health Blog » Bristol-Myers Loses ImClone but Gains $1 Billion

Posted 7 hours ago

Bristol-Myers Squibb lost out on acquiring ImClone today when Eli Lilly swooped in with a higher bid. But Bristol has come out of this thing looking pretty good.

Bristol already owned ...

[Link]



Pharmalot » Samples Don’t Reach Poor Kids & Have Safety Risks

Posted 7 hours ago

In an ideal world, free samples would help uninsured patients get a jump on treatment they may not otherwise be able to obtain. But a new study in Pediatrics finds that ...

[Link]



PharmaGossip » Keating - A "must watch" for McCain supporters

Posted 7 hours ago


This is the story that the media refuses to mention.

With the economic meltdown that we are witnessing, shouldn't the media be reminding the American people that John McCain was ...

[Link]



WSJ.com: Health Blog » Study Questions the Value of Free Drug Samples for Kids

Posted 8 hours ago

In an era when even the drug industry frowns on drug reps giving doctors trinkets and fancy gifts, the drug samples reps give docs to hand out free to patients are ...

[Link]



Pharmalot » Dendreon’s Provenge Reduced Prostate Cancer Risk

Posted 8 hours ago

Amid the stock sell-off, a bright spot appears and, of all things, it turns out to be Dendreon, the controversial and much-maligned little company that continues to press ahead with its ...

[Link]



Pharmalot » Dendreon’s Provenge Reduced Prostate Cancer Risk

Posted 8 hours ago

Amid the stock sell-off, a bright spot appears and, of all things, it turns out to be Dendreon, the controversial and much-maligned little company that continues to press ahead with its ...

[Link]



Pharmalot » University of Minnesota May Ban Pharma Gifts

Posted 10 hours ago

A university medical school task force recommends prohibiting faculty, medical residents and students from receiving gifts from drug and device makers, according to an unreleased report obtained by The Minnesota Daily, ...

[Link]



Pharmalot » Alpharma Agrees To Negotiate With King Pharma

Posted 10 hours ago

Are you surprised? After the usual posturing and harsh language, the two drugmakers have agreed to a confidentiality agreement, according to a filing with the US Securities and Exchange Commission. This, ...

[Link]



Pharmalot » University of Minnesota May Ban Pharma Gifts

Posted 10 hours ago

A university medical school task force recommends prohibiting faculty, medical residents and students from receiving gifts from drug and device makers, according to an unreleased report obtained by The Minnesota Daily, ...

[Link]



WSJ.com: Health Blog » Health Care Heats Up in Presidential Campaign

Posted 11 hours ago

Health wonks who worried that the global financial crisis would eclipse health care talk in the presidential campaign got some good news this weekend.

Barack Obama brought the subject back, attacking ...

[Link]



WSJ.com: Health Blog » Nobel Prize Eludes American in Long-Running HIV Dispute

Posted 11 hours ago


Luc Montagnier (left) and Robert Gallo. (AP Photo)

Half of this year’s Nobel Prize in Physiology or Medicine went to Françoise Barré-Sinoussi and Luc Montagnier, two French researchers who discovered ...

[Link]



PharmaGossip » Genentech /OSI - Avastin + Tarceva: clinical trials, ain't they a bitch?!

Posted 11 hours ago

Genentech and OSI Pharmaceuticals have announced top line results from a phase III study evaluating the combination of Avastin and Tarceva as second-line treatment for advanced non-small cell lung cancer. ... [Link]



Pharmalot » Alpharma Agrees To Negotiate With King Pharma

Posted 11 hours ago

Are you surprised? After the usual posturing and harsh language, the two drugmakers have agreed to a confidentiality agreement, according to a filing with the US Securities and Exchange Commission. This, ...

[Link]



In the Pipeline » Imclone Really Does Get Bought

Posted 12 hours ago

Well, it looks as if I'll finally be able to stop talking about Imclone: the word came out this morning that they've agreed to a $70/share deal with Lilly. Some thoughts ...

[Link]



Pharmalot » Roche Cuts Price Of Tarceva Cancer Med In UK

Posted 12 hours ago

To get convince the UK’s National Institute for Health and Clinical Excellence to pay for its lung cancer treatment, Roche had to cut the price by about $1,000 in order to ...

[Link]



Pharmalot » Lilly Agrees To Buy ImClone For $6.5 Billion

Posted 12 hours ago

After weeks of drama, a deal is finally done. Lilly will pay $70 a share, well above the $62 offered by Bristol-Myers Squibb. In doing so, Lilly gets access to the ...

[Link]



Pharmalot » Pharmalot… Pharmalittle… Good Morning

Posted 12 hours ago

Welcome back. We hope your weekend was enjoyable. We used our to catch up on sundry errands and tidy up around the Pharmalot corporate campus. Now, though, the time has come ...

[Link]



WSJ.com: Health Blog » What Financial Crisis? Eli Lilly Buying ImClone for $6.5 Billion

Posted 12 hours ago

Never mind the credit crunch. Pharma companies are sitting on cash, and they’re desperate to get into the biotech business. Eli Lilly said this morning that it has agreed to buy ...

[Link]



Pharmalot » Roche Cuts Price Of Tarceva Cancer Med In UK

Posted 12 hours ago

To get convince the UK’s National Institute for Health and Clinical Excellence to pay for its lung cancer treatment, Roche had to cut the price by about $1,000 in order to ...

[Link]



Pharmalot » Lilly Agrees To Buy ImClone For $6.5 Billion

Posted 13 hours ago

After weeks of drama, a deal is finally done. Lilly will pay $70 a share, well above the $62 offered by Bristol-Myers Squibb. In doing so, Lilly gets access to the ...

[Link]



PharmaGossip » Safety First

Posted 13 hours ago

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for October 2008 (PDF).

This issue provides a safety update for ergot-derived dopamine agonists and antibiotics ... [Link]



PharmaGossip » Desperate times call for desperate measures

Posted 13 hours ago


http://www.shatnerhasselhoff.com/ [Link]



Pharmalot » Pharmalot… Pharmalittle… Good Morning

Posted 13 hours ago

Welcome back. We hope your weekend was enjoyable. We used our to catch up on sundry errands and tidy up around the Pharmalot corporate campus. Now, though, the time has come ...

[Link]



Eye on FDA » Targeted Seats in the House of Representatives

Posted 13 hours ago

On Election Day 2008, all 435 seats in the United States House of Representatives will be up for grabs. attention so far in 2008, but these House races could arguably have the ... [Link]



The IN VIVO Blog » While You Were Advancing

Posted 13 hours ago

Despite Saturday's game three hiccup the Fightin' Phils advanced to the NLCS this weekend with a 6-2 win over Milwaukee to cap a 3-1 NLDS victory, taking the sting out ... [Link]



PharmaGossip » Health Care Journalists - problem or solution?

Posted 14 hours ago

Medical research conflicts of interest are in the news lately, thanks to recent congressional hearings by Senator Charles Grassley.

But are journalists part of the problem?

A new study in the Journal of ... [Link]



PharmaGossip » This years Ig Nobel Prize for Medicine

Posted 14 hours ago

MEDICINE PRIZE. Dan Ariely of Duke University (USA), Rebecca L. Waber of MIT (USA), Baba Shiv of Stanford University (USA), and Ziv Carmon of INSEAD (Singapore) for demonstrating that high-priced ... [Link]



PharmaGossip » Lilly beat BMS to ImClone

Posted 15 hours ago

ImClone has agreed to be acquired by Eli Lilly for about $6.1 billion, Reuters reports, citing sources familiar with the situation.

More [Link]



PharmaGossip » McCain and Keating

Posted 20 hours ago

http://www.keatingeconomics.com/

[Link]



PharmaGossip » BI / Pfizer - Spiriva: clinical trials, ain't they a bitch!?

Posted 20 hours ago

Spiriva, marketed by Pfizer and Boehringer Ingelheim, offered no advantage over an inhaled placebo for moderate-to-very-severe chronic obstructive pulmonary disease, or COPD, researchers reported on Sunday.

More

Also,
remember this. ... [Link]



Pharmalot » What Rules? Emory Fiddled While Nemeroff Earned

Posted 22 hours ago

For several years, Charles Nemeroff assured Emory University, where he chaired the psychiatry department, that he wouldn’t accept more than $10,000 in consulting fees from Glaxo, since he was the ...

[Link]



Pharmalot » What Rules? Emory Fiddled While Nemeroff Earned

Posted 24 hours ago

For several years, Charles Nemeroff assured Emory University, where he chaired the psychiatry department, that he wouldn’t accept more than $10,000 in consulting fees from Glaxo, since he was the ...

[Link]



THE PETER ROST BLOG » All these people are allowed to vote!

Posted 30 hours ago

By accessing this site, you are agreeing to comply with and be bound by the terms of use agreement and privacy policy. [Link]



THE PETER ROST BLOG » Congressional bailout press conference on SNL

Posted 31 hours ago

By accessing this site, you are agreeing to comply with and be bound by the terms of use agreement and privacy policy. [Link]



THE PETER ROST BLOG » Biden and Palin VP debate on SNL

Posted 31 hours ago

By accessing this site, you are agreeing to comply with and be bound by the terms of use agreement and privacy policy. [Link]



Pharm Aid » Free Drugs

Posted 32 hours ago

This article could be easily be entitled Hijacked Pharmaceuticals. Quietly, there is a growing problem of stolen pharmaceuticals in the United States.

Pharmaceuticals, like 70% of the products in the U.S., ... [Link]



PharmaGossip » Forest Laboratories - values and transfer pricing

Posted 36 hours ago




Howard Solomon , Chairman and Chief Executive Officer

Forest Laboratories, a US pharmaceutical firm, has channelled more than $2 billion in revenues through its Irish ... [Link]



PharmaGossip » Charles "King of Bling" Nemeroff - leader of the Pharma Psych Crew

Posted 38 hours ago

Back stories here and here.

But now - meet the new "King of Bling"! Emory's very own Chuck Nemeroff.

David Armstrong of the Wall Street Journal and Gardiner Harris of the New York ... [Link]



PharmaGossip » Well - it is Sunday!

Posted 39 hours ago

Religion - LOL.

Bill on The View:

http://uk.youtube.com/watch?v=dkfPZnyMaEY

http://uk.youtube.com/watch?v=nCrPWWqNl1I

[Link]



PharmaGossip » Let the subshine in

Posted 39 hours ago

Go Chuck go! [Link]



PharmaGossip » Late Nite Jokers

Posted 43 hours ago

[Link]



Want to keep tabs on the latest talk in the pharma industry blogosphere? Here you can check the latest posts from popular pharma blogs, updated throughout the day. To suggest a blog, please email webmaster@cafepharma.com.

 

Number of online users in last 3 minutes